文献速递免疫规划卫生政策与健康促进

炭疽疫苗沉淀(AVP)加强剂间隔时间延长可增强血清学应答

Serological responses to Anthrax Vaccine Precipitated (AVP) increase with time interval between booster doses.
PubMed 文献 · Vaccine · 2022-09-22

一项4期临床试验评估健康成人既往完成4剂基础免疫后,AVP加强剂间隔时间对血清学应答的影响。B组(距末次接种≥2年)各时间点较基线的倍数变化均高于A组(按程序接种),峰值应答与距末次接种时间正相关、与既往剂数负相关。2017年JCVI据此将英国炭疽疫苗常规加强间隔由1年延长至10年。

要点

  • B组(距末次≥2年)各时间点较基线倍数变化均高于A组(按程序接种)。
  • 峰值应答与距末次AVP时间正相关,≥10年间隔观察值最高。
  • 596份TNA结果分析显示抗PA与抗LF IgG对中和炭疽致死毒素有实质独立贡献。

核心结论

  • AVP加强剂可诱导针对炭疽毒素三种组分的显著IgG应答,尤其针对PA和LF。
  • TNA(公认的炭疽疫苗效力替代指标)中亦观察到类似高应答。
  • AVP可能较仅依赖诱导PA免疫力的炭疽疫苗具有优势。

研究设计与样本

  • 4期临床试验,评估既往完成4剂基础免疫的健康成人中AVP加强剂间隔时间对血清学应答的影响。
  • A组按程序接种,B组距末次接种≥2年。
  • 第1天给药前及第8、15、29、120天采血,用ELISA测抗PA、LF、EF IgG浓度,用TNA测NF50值。

主要发现

  • 每个血清学参数在试验AVP剂量后较基线的倍数变化,B组在所有研究时间点均高于A组。
  • 峰值应答与距末次AVP剂量的时间正相关,≥10年间隔观察值最高。
  • 峰值应答与既往剂数负相关,仅接受过基础免疫者观察值最高。
  • 596份TNA结果分析显示抗PA和抗LF IgG对中和炭疽致死毒素有实质独立贡献。

关键数值与推荐

  • 2017年JCVI审查这些结果后更新英国炭疽疫苗接种指南,将常规AVP加强剂间隔从1年延长至10年。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We undertook a Phase 4 clinical trial to assess the effect of time interval between booster doses on serological responses to AVP. The primary objective was to evaluate responses to a single booster dose in two groups of healthy adults who had previously received a complete 4-dose primary course. Group A had received doses on schedule while Group B had not had one for ≥2 years. Secondary objectives were to evaluate the safety and tolerability of AVP booster doses, and to gain information on correlates of protection to aid future anthrax vaccine development. Blood samples were taken on Day 1 before dosing, and on Days 8, 15, 29 and 120, to measure Toxin Neutralisation Assay (TNA) NF50 values and concentrations of IgG antibodies against Protective Antigen (PA), Lethal Factor (LF) and Edema Factor (EF) by ELISA. For each serological parameter, fold changes from baseline following the trial AVP dose were greater in Group B than Group A at every time-point studied. Peak responses correlated positively with time since last AVP dose (highest values being observed after intervals of ≥10 years), and negatively with number of previous doses (highest values occurring in individuals who had received a primary course only). In 2017, having reviewed these results, the Joint Committee on Vaccination and Immunisation (JCVI) updated UK anthrax vaccination guidelines, extending the interval between routine AVP boosters from one to 10 years. Booster doses of AVP induce significant IgG responses against the three anthrax toxin components, particularly PA and LF. Similarly high responses were observed in TNA, a recognised surrogate for anthrax vaccine efficacy. Analysis of the 596 TNA results showed that anti-PA and anti-LF IgG make substantial independent contributions to neutralisation of anthrax lethal toxin. AVP may therefore have advantages over anthrax vaccines that depend on generating immunity to PA alone.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Dyson EH, Simpson AJH, Gwyther RJ, et al. Serological responses to Anthrax Vaccine Precipitated (AVP) increase with time interval between booster doses. Vaccine. 2022. PMID: 36153153. doi:10.1016/j.vaccine.2022.08.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。